CDKN2B-AS1 rs3087456: What Your Genotype Means
The rs3087456 variant is a genetic marker located within the CDKN2B-AS1 region on chromosome 9. It is primarily studied for its statistical association with primary open-angle glaucoma (POAG) and related optic nerve traits.
What each genotype means
Increased glaucoma risk
This genotype is associated with a higher statistical risk for primary open-angle glaucoma compared to the alternative allele. Research indicates this variant in the CDKN2B-AS1 region may influence optic disc traits, which are clinical markers for glaucoma. This association is based on population-level data and does not predict an individual diagnosis.
This genotype is common in many global populations, though exact frequencies vary significantly by ancestry.
Intermediate glaucoma risk
Carrying one copy of each allele places you in an intermediate category regarding the statistical association with primary open-angle glaucoma. This variant is linked to changes in optic disc structure, which are relevant to glaucoma development. These findings reflect population trends and should be discussed with an eye care professional during routine screenings.
This heterozygous genotype is frequently observed across diverse ancestral groups.
Baseline glaucoma risk
This genotype is considered the baseline or reference state in studies examining the association between this variant and primary open-angle glaucoma. It does not carry the increased risk markers identified in the A-allele carriers. As with all genetic findings, this represents a statistical association rather than a guarantee of health or disease status.
This genotype is common in most populations, appearing at varying frequencies depending on geographic and ancestral background.
Understanding the rs3087456 Variant
The rs3087456 variant is a single nucleotide polymorphism (SNP) situated in the 9p21.3 chromosomal region. This specific area is well-known in genomics for housing the CDKN2B-AS1 gene, which produces a long non-coding RNA. Unlike protein-coding genes that provide instructions for building physical structures in the body, non-coding RNAs often act as regulators, influencing how other genes are expressed. Because rs3087456 sits within this regulatory landscape, researchers investigate whether it alters the activity of nearby genes, such as CDKN2B, which are involved in cell cycle regulation and senescence. By studying this SNP, scientists aim to understand the molecular mechanisms that might contribute to the structural changes observed in the optic nerve, which is a critical component of vision health.
The Role of the CDKN2B-AS1 Region
The CDKN2B-AS1 gene and its surrounding region are frequently implicated in studies regarding primary open-angle glaucoma (POAG). Research suggests that this locus may influence the health of retinal ganglion cells, which are the neurons that transmit visual information from the eye to the brain. When these cells degenerate, it can lead to the characteristic optic nerve damage seen in glaucoma. Studies using luciferase reporter assays and other molecular techniques have suggested that the region surrounding these variants may function as a transcriptional repressor. When the expression of these genes is disrupted, it may affect how cells in the eye respond to stress or pressure. While the exact biological pathway remains a subject of active investigation, the 9p21 locus is considered a significant area of interest for understanding the genetic architecture of eye-related conditions.
Research and Evidence Strength
The association between variants in the CDKN2B-AS1 region and glaucoma is supported by numerous genome-wide association studies (GWAS). While rs3087456 is recognized as part of this broader risk locus, the evidence for any single SNP's individual impact can vary depending on the population studied. Many studies have observed that these variants correlate with endophenotypic traits, such as the cup-to-disc ratio, which measures the size of the optic nerve cup relative to the total disc. However, it is important to note that genetic associations are statistical in nature and do not guarantee the development of a condition. The field is currently moving toward larger, more diverse studies to determine how these variants interact with environmental factors and other genes. Current evidence is considered limited in terms of clinical predictive power, meaning this information is primarily used for research purposes rather than individual diagnostic screening.
Population Frequency and Diversity
The frequency of variants in the CDKN2B-AS1 region can differ significantly across global populations. Some alleles that are common in European-descent cohorts may be rare or absent in other ancestral groups, and vice versa. This variation is a critical consideration in genomics, as it highlights the importance of studying diverse cohorts to ensure that findings are applicable to everyone. For instance, researchers have noted that local genetic ancestry at this locus can be a strong predictor of glaucoma risk in specific populations, such as African Americans. Because the prevalence of these alleles is not uniform, the statistical risk associated with a specific genotype may change depending on an individual's genetic background. Understanding these differences is a major focus of current research, as it helps scientists refine their models and avoid making broad generalizations based on limited data.
What This Information Means for You
If you have information about your rs3087456 genotype, it is important to view it through the lens of scientific research rather than clinical diagnosis. Genetic variants are only one piece of a complex puzzle that includes age, family history, lifestyle, and regular eye examinations. Having a specific genotype does not mean you will develop glaucoma, nor does the absence of a risk allele guarantee protection. This information is intended for educational purposes and should not be used to make health decisions. If you are concerned about your eye health or have a family history of glaucoma, the most effective step is to consult with an ophthalmologist or optometrist. They can perform clinical tests, such as measuring intraocular pressure and examining the optic nerve, which are the standard methods for monitoring eye health and managing potential risks.
How common is this variant?
The rs3087456 variant is common in most global populations, though the specific frequency of each allele can vary significantly depending on ancestral background.
Frequently asked questions
Does having a risk genotype mean I will get glaucoma?
No. Genetic variants are statistical associations, not diagnostic tools. Many people with risk alleles never develop the condition, and many without them do.
Can I use this information to prevent glaucoma?
Genetic information cannot be used to prevent glaucoma. The best way to manage your eye health is to schedule regular comprehensive eye exams with an eye care professional.
Why do studies show different results for this variant?
Differences in results often stem from the diversity of the populations studied, sample sizes, and the specific environmental factors present in those groups. Genetic associations are rarely universal across all ancestries.
Is this variant related to other health conditions?
The 9p21 region is well-studied for its association with various conditions, including cardiovascular health. However, rs3087456 is specifically highlighted in literature for its link to glaucoma-related traits.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3087456?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B
This variant is a well-established risk factor for coronary artery disease and related cardiovascular conditions.
This SNP is a well-replicated marker for cardiovascular disease risk and myocardial infarction susceptibility.
This variant is associated with increased risk for coronary artery disease and related cardiovascular conditions.
This SNP has been identified as a susceptibility marker for meningioma risk in genome-wide association studies.
A noncoding variant modulating the senescence pathway at chromosome 9p21 linked to differential survival rates into extreme age (>90 years).